Hepatocellular Carcinoma Non-resectable

2 competing products in clinical development for Hepatocellular Carcinoma Non-resectable.

Pipeline by Phase

Phase 1/21
Phase 21

All Products (2)

ProductCompanyStageStatusHype
mFOLFOX7 combined with Camrelizumab and apatinibSun PharmaceuticalPhase 2Recruiting
42
LenvatinibEisaiPhase 1/2Active
36